However, in many cases, especially in recurrent GBM, the MGMT promoter is in its unmethylated (active) state, which leads to the repair of methylated nucleotides and the development of resistance to TMZ treatment (Kitange et al., 2009) [19]. The gene discussed is MGMT; the disease is glioblastoma.